KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,587,000 | -98.8% | 316,133 | +8307.8% | 1.47% | -63.2% |
| Q2 2022 | $383,233,000 | +3446.8% | 3,760 | -99.0% | 4.00% | +64.1% |
| Q1 2022 | $10,805,000 | +113.3% | 383,233 | 0.0% | 2.44% | +115.9% |
| Q4 2021 | $5,066,000 | -24.2% | 383,233 | 0.0% | 1.13% | -30.0% |
| Q3 2021 | $6,687,000 | -1.5% | 383,233 | +35.3% | 1.61% | -10.0% |
| Q2 2021 | $6,786,000 | +23.7% | 283,233 | +32.0% | 1.79% | +23.5% |
| Q1 2021 | $5,486,000 | +62.8% | 214,533 | +20.9% | 1.45% | +57.7% |
| Q4 2020 | $3,369,000 | +50.9% | 177,433 | 0.0% | 0.92% | +27.6% |
| Q3 2020 | $2,232,000 | -0.6% | 177,433 | 0.0% | 0.72% | -3.5% |
| Q2 2020 | $2,246,000 | +29.8% | 177,433 | -22.0% | 0.75% | -5.3% |
| Q1 2020 | $1,731,000 | -64.8% | 227,433 | -18.0% | 0.79% | -55.5% |
| Q4 2019 | $4,924,000 | +139.3% | 277,433 | +56.4% | 1.77% | +86.5% |
| Q3 2019 | $2,058,000 | -50.6% | 177,433 | -5.4% | 0.95% | -38.4% |
| Q2 2019 | $4,165,000 | -31.3% | 187,599 | -12.0% | 1.54% | -31.1% |
| Q1 2019 | $6,062,000 | +22.4% | 213,061 | -33.3% | 2.24% | -27.1% |
| Q4 2018 | $4,954,000 | -9.4% | 319,444 | -0.9% | 3.07% | +18.3% |
| Q3 2018 | $5,467,000 | +109.3% | 322,436 | 0.0% | 2.60% | +159.0% |
| Q2 2018 | $2,612,000 | -13.2% | 322,436 | 0.0% | 1.00% | -14.5% |
| Q1 2018 | $3,008,000 | -4.1% | 322,436 | 0.0% | 1.17% | +6.1% |
| Q4 2017 | $3,137,000 | +46.1% | 322,436 | 0.0% | 1.11% | +32.3% |
| Q3 2017 | $2,147,000 | -5.7% | 322,436 | 0.0% | 0.84% | -3.4% |
| Q2 2017 | $2,276,000 | -9.6% | 322,436 | 0.0% | 0.86% | -10.3% |
| Q1 2017 | $2,518,000 | +15.2% | 322,436 | 0.0% | 0.96% | -2.1% |
| Q4 2016 | $2,186,000 | – | 322,436 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |